FDA headquarters, MarylandRemoving hemp from the federal narcotics Schedule 1 list does not mean that all CBD products are now permitted, the US Food and Drug Administration (FDA) has warned.

Following passage of the Farm Bill which deschedules hemp, FDA commissioner Scott Gottlieb said that “increasing public interest in [cannabis-derived] products makes it even more important…for the FDA to clarify its regulatory authority over these products”.

That authority would continue to be exercised over food and drugs “regardless of the source of the substance, including whether the substance is derived from a plant that is classified as hemp under the Agriculture Improvement Act”, he said.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us